Holen Sie sich die Stockscreener-App
6.20
4.76%
-0.31
Handel nachbörslich:
6.30
0.10
+1.61%
Schlusskurs vom Vortag:
$6.51
Offen:
$6.57
24-Stunden-Volumen:
524.73K
Relative Volume:
1.38
Marktkapitalisierung:
$399.73M
Einnahmen:
-
Nettoeinkommen (Verlust:
$-45.08M
KGV:
-8.4932
EPS:
-0.73
Netto-Cashflow:
$-33.68M
1W Leistung:
+4.38%
1M Leistung:
+12.52%
6M Leistung:
+316.11%
1J Leistung:
+168.40%
1-Tages-Spanne:
$6.03
$6.78
1-Wochen-Bereich:
$5.10
$6.78
52-Wochen-Spanne:
$0.726
$6.78
Galectin Therapeutics Inc Stock (GALT) Company Profile
Firmenname
Galectin Therapeutics Inc
Sektor
Branche
Telefon
678-620-3186
Adresse
4960 PEACHTREE INDUSTRIAL BOULEVARD, NORCROSS, GA
Vergleichen Sie GALT mit anderen Aktien
| Aktien | Preis | Marktkapitalisierung | Umsatz | Nettogewinn | Free Cashflow | ENV |
|---|---|---|---|---|---|---|
GALT
Galectin Therapeutics Inc
|
6.20 | 419.72M | 0 | -45.08M | -33.68M | -0.73 |
|
VRTX
Vertex Pharmaceuticals Inc
|
454.96 | 115.62B | 11.74B | 3.68B | 3.34B | 14.19 |
|
REGN
Regeneron Pharmaceuticals Inc
|
746.36 | 79.10B | 14.25B | 4.58B | 3.88B | 41.77 |
|
ARGX
Argen X Se Adr
|
851.42 | 52.39B | 3.06B | 1.28B | 447.35M | 19.67 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
391.17 | 51.72B | 3.21B | 43.57M | 221.36M | 0.2405 |
|
INSM
Insmed Inc
|
200.67 | 42.00B | 447.02M | -1.18B | -906.14M | -6.1812 |
Galectin Therapeutics Inc Stock (GALT) Upgrades & Downgrades
| Datum | Aktion | Analytiker | Ratingänderung |
|---|---|---|---|
| 2025-06-17 | Fortgesetzt | H.C. Wainwright | Buy |
| 2020-08-13 | Bestätigt | H.C. Wainwright | Buy |
| 2019-02-13 | Eingeleitet | B. Riley FBR | Buy |
| 2017-12-07 | Bestätigt | H.C. Wainwright | Buy |
| 2017-11-28 | Bestätigt | H.C. Wainwright | Buy |
| 2017-10-19 | Eingeleitet | ROTH Capital | Buy |
| 2017-03-30 | Hochstufung | H.C. Wainwright | Neutral → Buy |
| 2016-10-03 | Herabstufung | FBR & Co. | Outperform → Mkt Perform |
| 2016-09-29 | Herabstufung | H.C. Wainwright | Buy → Neutral |
| 2016-09-28 | Herabstufung | ROTH Capital | Buy → Sell |
| 2016-03-28 | Fortgesetzt | H.C. Wainwright | Buy |
| 2015-09-21 | Eingeleitet | H.C. Wainwright | Buy |
| 2014-08-01 | Herabstufung | Aegis Capital | Buy → Hold |
| 2014-07-30 | Bestätigt | MLV & Co | Buy |
| 2014-07-29 | Bestätigt | MLV & Co | Buy |
| 2014-04-02 | Bestätigt | MLV & Co | Buy |
| 2014-02-10 | Bestätigt | Aegis Capital | Buy |
| 2014-01-09 | Bestätigt | Aegis Capital | Buy |
| 2013-12-03 | Eingeleitet | MLV & Co | Buy |
| 2013-08-19 | Bestätigt | Aegis Capital | Buy |
Alle ansehen
Galectin Therapeutics Inc Aktie (GALT) Neueste Nachrichten
Fundamentals Check: Will Galectin Therapeutics Inc stock benefit from AI adoptionDay Trade & Real-Time Market Sentiment Alerts - moha.gov.vn
Market Pulse: Will Galectin Therapeutics Inc stock benefit from AI adoptionJuly 2025 Sentiment & Daily Stock Trend Watchlist - moha.gov.vn
Galectin therapeutics director sells shares worth $1.05 million By Investing.com - Investing.com Canada
Galectin Therapeutics (NASDAQ:GALT) Director Sells $105,273.30 in Stock - MarketBeat
Galectin Therapeutics (NASDAQ:GALT) Director Sells $950,820.00 in Stock - MarketBeat
Galectin therapeutics director sells shares worth $1.05 million - Investing.com India
Galectin Therapeutics Insider Sold Shares Worth $1,055,311, According to a Recent SEC Filing - marketscreener.com
Dir Shlevin Sells 175,790 ($1.1M) Of Galectin Therapeutics Inc [GALT] - TradingView — Track All Markets
There is no way Galectin Therapeutics Inc (GALT) can keep these numbers up - Setenews
Galectin Therapeutics shareholders elect board members and approve key proposals By Investing.com - Investing.com Nigeria
10x fund sells Galectin Therapeutics (GALT) shares worth $920,855 By Investing.com - Investing.com Australia
10x fund sells Galectin Therapeutics (GALT) shares worth $920,855 - Investing.com
Galectin Therapeutics : Amendment to Statement of Changes in Beneficial Ownership (Form 4/A) - marketscreener.com
Galectin Therapeutics shareholders elect board members and approve key proposals - Investing.com
Galectin Therapeutics (NASDAQ:GALT) Major Shareholder Fund L.P. 10X Sells 30,000 Shares - MarketBeat
Prepare Yourself for Liftoff: Galectin Therapeutics Inc (GALT) - Setenews
How Galectin Therapeutics Inc. (PHPN) stock reacts to Fed tighteningJuly 2025 Volume & Daily Growth Stock Tips - Newser
Is Galectin Therapeutics Inc. (PHPN) stock a contrarian opportunityBear Alert & Safe Capital Growth Stock Tips - Newser
10x fund sells Galectin therapeutics (GALT) shares worth $851,700 By Investing.com - Investing.com Canada
10x fund sells Galectin therapeutics (GALT) shares worth $851,700 - Investing.com
Will Galectin Therapeutics Inc. (PHPN) stock benefit from commodity supercycleJuly 2025 Rallies & Short-Term High Return Strategies - Newser
Clinical Progress Drives Galectin Shares Up Post-NAVIGATE Data (NASDAQ:GALT) - Seeking Alpha
Is Galectin Therapeutics Inc. (PHPN) stock a buy on weaknessWeekly Trade Review & Community Consensus Stock Picks - Newser
Is Galectin Therapeutics Inc. (PHPN) stock undervalued historicallyQuarterly Risk Review & High Win Rate Trade Alerts - Newser
Will Galectin Therapeutics Inc. (PHPN) stock rise with strong economy2025 Stock Rankings & Growth Oriented Trading Recommendations - Newser
Can Galectin Therapeutics Inc. (PHPN) stock double in coming yearsQuarterly Profit Report & Daily Growth Stock Tips - Newser
Galectin Therapeutics Reveals Promising NAVIGATE Trial Results - TipRanks
Galectin Therapeutics Inc Presents NAVIGATE Trial Results - TradingView — Track All Markets
Will Galectin Therapeutics Inc. (PHPN) stock sustain bullish trend into 2025Quarterly Growth Report & High Accuracy Investment Entry Signals - Newser
Will Galectin Therapeutics Inc. (PHPN) stock beat international competitionJuly 2025 Snapshot & Stepwise Entry/Exit Trade Alerts - Newser
How big funds are accumulating Galectin Therapeutics Inc. (PHPN) stockMarket Activity Report & Weekly Chart Analysis and Guides - Newser
Why Galectin Therapeutics Inc. stock is favored by pension fundsJuly 2025 Review & Free Technical Confirmation Trade Alerts - BỘ NỘI VỤ
Galectin Therapeutics (NASDAQ:GALT) Shares Cross Above 200 Day Moving AverageTime to Sell? - MarketBeat
The growth track for Galectin Therapeutics Inc (GALT) has changed recently - setenews.com
Will Galectin Therapeutics Inc. stock sustain high P E ratiosTrade Volume Summary & Weekly High Potential Alerts - BỘ NỘI VỤ
Galectin Therapeutics Stock: NAVIGATE Data Validates The Fibrosis Thesis (NASDAQ:GALT) - Seeking Alpha
Wealthspire Advisors LLC Buys 81,144 Shares of Galectin Therapeutics Inc. $GALT - MarketBeat
How Galectin Therapeutics Inc. stock reacts to Fed rate cutsDip Buying & Stepwise Trade Execution Plans - newser.com
Finanzdaten der Galectin Therapeutics Inc-Aktie (GALT)
Umsatz
Nettogewinn
Free Cashflow
ENV
0.39%
1.90%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):